Evidence map›Paper›PMID 31176455›Full record

ArticleThe Journal of pediatrics2019

Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry.

Mei-Sing Ong, Steve Abman, Eric D Austin, Jeffrey A Feinstein, Rachel K Hopper, Usha S Krishnan, Mary P Mullen, Marc D Natter, J Usha Raj, Erika B Rosenzweig and 2 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The Journal of pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  6. Article
  7. Review
  8. Pulmonary vasodilator use in very preterm infants in United States children's hospitals.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Under Pressure: The Pulmonary Vasculature and Its Role in the Pediatric Cardiac ICU.American journal of respiratory and critical care medicine · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Mei-Sing OngDepartment of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA; Computational Health Informatics Program, Harvard Medical School & Boston Children's Hospital, Boston, MA. Electronic address: Mei-Sing_Ong@hms.harvard.edu.
Steve AbmanDepartment of Pediatric Pulmonary Medicine, Children's Hospital Colorado, University of Colorado School of Medicine, Denver, CO.
Eric D AustinDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
Jeffrey A FeinsteinDepartment of Pediatrics (Cardiology), Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, Palo Alto, CA.
Rachel K HopperDepartment of Pediatrics (Cardiology), Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, Palo Alto, CA.
Usha S KrishnanDepartment of Pediatrics (Pediatric Cardiology), Columbia University Medical Center, New York-Presbyterian Children's Hospital, New York, NY.
Mary P MullenDepartment of Cardiology, Harvard Medical School, Boston Children's Hospital, Boston, MA.
Marc D NatterComputational Health Informatics Program, Harvard Medical School & Boston Children's Hospital, Boston, MA.
J Usha RajDepartment of Pediatrics, University of Illinois, Chicago, IL.
Erika B RosenzweigDepartment of Pediatrics (Pediatric Cardiology), Columbia University Medical Center, New York-Presbyterian Children's Hospital, New York, NY.
Kenneth D MandlComputational Health Informatics Program, Harvard Medical School & Boston Children's Hospital, Boston, MA.
Pediatric Pulmonary Hypertension Network and National Heart, Lung, and Blood Institute Pediatric Pulmonary Vascular Disease Outcomes Bioinformatics Clinical Coordinating Center Investigators
Harvard University · USColumbia University Irving Medical Center · USStanford University · USBoston Children's Hospital · USChildren's Hospital Colorado · USUniversity of Illinois Chicago · USVanderbilt University Medical Center · US

Funding

Data Fusion: A Sustainable, Scalable, Open Source Registry Advancing PVD ResearchU01HL121518 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ABMAN, STEVEN HERBERT, MANDL, KENNETH D. · 2014 to 2018
$9.3M
NHLBI NIH HHS U01 HL121518
6 · The paper itself

Abstract

objectiveTo investigate racial and ethnic differences in pulmonary hypertension subtypes and survival differences in a pediatric population. STUDY

designThis was a retrospective analysis of a cohort of patients with pulmonary hypertension (aged ≤18 years) enrolled in the Pediatric Pulmonary Hypertension Network registry between 2014 and 2018, comprising patients at eight Pediatric Centers throughout North America (n = 1417).

resultsAmong children diagnosed after the neonatal period, pulmonary arterial hypertension was more prevalent among Asians (OR, 1.83; 95% CI, 1.21-2.79; P = .0045), lung disease-associated pulmonary hypertension among blacks (OR, 2.09; 95% CI, 1.48-2.95; P < .0001), idiopathic pulmonary arterial hypertension among whites (OR, 1.58; 95% CI, 1.06-2.41; P = .0289), and pulmonary veno-occlusive disease among Hispanics (OR, 6.11; 95% CI, 1.34-31.3; P = .0184). Among neonates, persistent pulmonary hypertension of the newborn (OR, 4.07; 95% CI, 1.54-10.0; P = .0029) and bronchopulmonary dysplasia (OR, 8.11; 95% CI, 3.28-19.8; P < .0001) were more prevalent among blacks, and congenital diaphragmatic hernia was more prevalent among whites (OR, 2.29; 95% CI, 1.25-4.18; P = .0070). An increased mortality risk was observed among blacks (HR, 1.99; 95% CI, 1.03-3.84; P = .0396), driven primarily by the heightened mortality risk among those with lung disease-associated pulmonary hypertension (HR, 2.84; 95% CI, 1.15-7.04; P = .0241).

conclusionsWe found significant racial variability in the prevalence of pulmonary hypertension subtypes and survival outcomes among children with pulmonary hypertension. Given the substantial burden of this disease, further studies to validate phenotypic differences and to understand the underlying causes of survival disparities between racial and ethnic groups are warranted.

Indexed as

RegistriesAdolescentBlack or African AmericanChildChild, PreschoolEthnicityFemaleHispanic or LatinoHumansInfantInfant, NewbornMaleNorth AmericaPediatricsPrevalencePulmonary Arterial Hypertension

Identifiers

PMID31176455
PMCPMC6776463
OpenAlexW2955158622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.